Cargando…

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study

BACKGROUND: Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-termi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Erika, Wei, Janet, Nelson, Michael D., Bakir, May, Mehta, Puja K., Shufelt, Chrisandra, Minissian, Margo, Sharif, Behzad, Pepine, Carl J., Handberg, Eileen, Cook-Wiens, Galen, Sopko, George, Bairey Merz, C. Noel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714343/
https://www.ncbi.nlm.nih.gov/pubmed/33270715
http://dx.doi.org/10.1371/journal.pone.0243213
_version_ 1783618735860350976
author Jones, Erika
Wei, Janet
Nelson, Michael D.
Bakir, May
Mehta, Puja K.
Shufelt, Chrisandra
Minissian, Margo
Sharif, Behzad
Pepine, Carl J.
Handberg, Eileen
Cook-Wiens, Galen
Sopko, George
Bairey Merz, C. Noel
author_facet Jones, Erika
Wei, Janet
Nelson, Michael D.
Bakir, May
Mehta, Puja K.
Shufelt, Chrisandra
Minissian, Margo
Sharif, Behzad
Pepine, Carl J.
Handberg, Eileen
Cook-Wiens, Galen
Sopko, George
Bairey Merz, C. Noel
author_sort Jones, Erika
collection PubMed
description BACKGROUND: Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. METHODS: We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. RESULTS: Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = <0.0001), and indirectly with body mass index (r = -0.21, p = 0.0006), but did not independently associate with CFR. When stratified by NT-proBNP thresholds, higher NT-proBNP was initially associated with lower CFR, which did not persist with adjustment for multiple testing (p = 0.01 and 0.36, respectively). CONCLUSION: Among women with symptoms and signs of ischemia, preserved LVEF, no obstructive CAD, and undergoing clinically indicated functional coronary angiography (FCA) for suspected CMD, while a majority had elevated resting LVEDP, we failed to find an independent association between CFR and NT-proBNP, although stratified clinical thresholds may relate to lower CFR. Further work is needed to investigate if these findings support the hypothesis that CMD-related ischemia may be a precursor to HFpEF.
format Online
Article
Text
id pubmed-7714343
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-77143432020-12-09 N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study Jones, Erika Wei, Janet Nelson, Michael D. Bakir, May Mehta, Puja K. Shufelt, Chrisandra Minissian, Margo Sharif, Behzad Pepine, Carl J. Handberg, Eileen Cook-Wiens, Galen Sopko, George Bairey Merz, C. Noel PLoS One Research Article BACKGROUND: Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. METHODS: We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. RESULTS: Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = <0.0001), and indirectly with body mass index (r = -0.21, p = 0.0006), but did not independently associate with CFR. When stratified by NT-proBNP thresholds, higher NT-proBNP was initially associated with lower CFR, which did not persist with adjustment for multiple testing (p = 0.01 and 0.36, respectively). CONCLUSION: Among women with symptoms and signs of ischemia, preserved LVEF, no obstructive CAD, and undergoing clinically indicated functional coronary angiography (FCA) for suspected CMD, while a majority had elevated resting LVEDP, we failed to find an independent association between CFR and NT-proBNP, although stratified clinical thresholds may relate to lower CFR. Further work is needed to investigate if these findings support the hypothesis that CMD-related ischemia may be a precursor to HFpEF. Public Library of Science 2020-12-03 /pmc/articles/PMC7714343/ /pubmed/33270715 http://dx.doi.org/10.1371/journal.pone.0243213 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Jones, Erika
Wei, Janet
Nelson, Michael D.
Bakir, May
Mehta, Puja K.
Shufelt, Chrisandra
Minissian, Margo
Sharif, Behzad
Pepine, Carl J.
Handberg, Eileen
Cook-Wiens, Galen
Sopko, George
Bairey Merz, C. Noel
N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
title N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
title_full N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
title_fullStr N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
title_full_unstemmed N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
title_short N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
title_sort n-terminal pro-b-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: a report from the women’s ischemia syndrome evaluation–coronary vascular dysfunction (wise-cvd) study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714343/
https://www.ncbi.nlm.nih.gov/pubmed/33270715
http://dx.doi.org/10.1371/journal.pone.0243213
work_keys_str_mv AT joneserika nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT weijanet nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT nelsonmichaeld nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT bakirmay nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT mehtapujak nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT shufeltchrisandra nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT minissianmargo nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT sharifbehzad nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT pepinecarlj nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT handbergeileen nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT cookwiensgalen nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT sopkogeorge nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy
AT baireymerzcnoel nterminalprobtypenatriureticpeptideandcoronarymicrovasculardysfunctioninwomenwithpreservedejectionfractionareportfromthewomensischemiasyndromeevaluationcoronaryvasculardysfunctionwisecvdstudy